Friday, biopharmaceutical company Auxilium Pharmaceuticals Inc. (AUXL), said it has priced an underwritten initial public offering of 3 million shares of its common stock. The company also granted the underwriters a 30-day option to purchase up to 450 thousand shares to cover over-allotments, if any. The sale is expected to settle close on September 30, 2009, subject to customary closing conditions.
Jefferies & Company is acting as sole book-running manager in this offering.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.